Literature DB >> 21130160

The lipid peroxidation products 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote the formation of α-synuclein oligomers with distinct biochemical, morphological, and functional properties.

Thomas Näsström1, Therese Fagerqvist, Mikael Barbu, Mikael Karlsson, Fredrik Nikolajeff, Alex Kasrayan, Monica Ekberg, Lars Lannfelt, Martin Ingelsson, Joakim Bergström.   

Abstract

Oxidative stress has been implicated in the etiology of neurodegenerative disorders with α-synuclein pathology. Lipid peroxidation products such as 4-oxo-2-nonenal (ONE) and 4-hydroxy-2-nonenal (HNE) can covalently modify and structurally alter proteins. Herein, we have characterized ONE- or HNE-induced α-synuclein oligomers. Our results demonstrate that both oligomers are rich in β-sheet structure and have a molecular weight of about 2000 kDa. Atomic force microscopy analysis revealed that ONE-induced α-synuclein oligomers were relatively amorphous, with a diameter of 40-80 nm and a height of 4-8 nm. In contrast, the HNE-induced α-synuclein oligomers had a protofibril-like morphology with a width of 100-200 nm and a height of 2-4 nm. Furthermore, neither oligomer type polymerized into amyloid-like fibrils despite prolonged incubation. Although more SDS and urea stable, because of a higher degree of cross-linking, ONE-induced α-synuclein oligomers were less compact and more sensitive to proteinase K treatment. Finally, both ONE- and HNE-induced α-synuclein oligomers were cytotoxic when added exogenously to a neuroblastoma cell line, but HNE-induced α-synuclein oligomers were taken up by the cells to a significantly higher degree. Despite nearly identical chemical structures, ONE and HNE induce the formation of off-pathway α-synuclein oligomers with distinct biochemical, morphological, and functional properties.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21130160     DOI: 10.1016/j.freeradbiomed.2010.11.027

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  43 in total

1.  Effects of impaired membrane interactions on α-synuclein aggregation and neurotoxicity.

Authors:  Daniel Ysselstein; Mehul Joshi; Vartika Mishra; Amy M Griggs; Josephat M Asiago; George P McCabe; Lia A Stanciu; Carol Beth Post; Jean-Christophe Rochet
Journal:  Neurobiol Dis       Date:  2015-04-27       Impact factor: 5.996

2.  Elucidating the aggregation number of dopamine-induced α-synuclein oligomeric assemblies.

Authors:  Niels Zijlstra; Mireille M A E Claessens; Christian Blum; Vinod Subramaniam
Journal:  Biophys J       Date:  2014-01-21       Impact factor: 4.033

Review 3.  4-Hydroxy-nonenal-A Bioactive Lipid Peroxidation Product.

Authors:  Rudolf J Schaur; Werner Siems; Nikolaus Bresgen; Peter M Eckl
Journal:  Biomolecules       Date:  2015-09-30

4.  Intercellular transfer of pathogenic α-synuclein by extracellular vesicles is induced by the lipid peroxidation product 4-hydroxynonenal.

Authors:  Shi Zhang; Erez Eitan; Tsung-Yu Wu; Mark P Mattson
Journal:  Neurobiol Aging       Date:  2017-09-22       Impact factor: 4.673

5.  Chemoproteomics Reveals Chemical Diversity and Dynamics of 4-Oxo-2-nonenal Modifications in Cells.

Authors:  Rui Sun; Ling Fu; Keke Liu; Caiping Tian; Yong Yang; Keri A Tallman; Ned A Porter; Daniel C Liebler; Jing Yang
Journal:  Mol Cell Proteomics       Date:  2017-08-16       Impact factor: 5.911

6.  Small amphipathic molecules modulate secondary structure and amyloid fibril-forming kinetics of Alzheimer disease peptide Aβ(1-42).

Authors:  Timothy M Ryan; Anna Friedhuber; Monica Lind; Geoffrey J Howlett; Colin Masters; Blaine R Roberts
Journal:  J Biol Chem       Date:  2012-03-29       Impact factor: 5.157

7.  Vesicular uptake blockade generates the toxic dopamine metabolite 3,4-dihydroxyphenylacetaldehyde in PC12 cells: relevance to the pathogenesis of Parkinson's disease.

Authors:  David S Goldstein; Patti Sullivan; Adele Cooney; Yunden Jinsmaa; Rachel Sullivan; Daniel J Gross; Courtney Holmes; Irwin J Kopin; Yehonatan Sharabi
Journal:  J Neurochem       Date:  2012-10-25       Impact factor: 5.372

8.  Extracellular alpha-synuclein oligomers modulate synaptic transmission and impair LTP via NMDA-receptor activation.

Authors:  Maria José Diógenes; Raquel B Dias; Diogo M Rombo; Hugo Vicente Miranda; Francesca Maiolino; Patrícia Guerreiro; Thomas Näsström; Henri G Franquelim; Luís M A Oliveira; Miguel A R B Castanho; Lars Lannfelt; Joakim Bergström; Martin Ingelsson; Alexandre Quintas; Ana M Sebastião; Luísa V Lopes; Tiago Fleming Outeiro
Journal:  J Neurosci       Date:  2012-08-22       Impact factor: 6.167

Review 9.  α-Synuclein in Extracellular Vesicles: Functional Implications and Diagnostic Opportunities.

Authors:  Camilla Lööv; Clemens R Scherzer; Bradley T Hyman; Xandra O Breakefield; Martin Ingelsson
Journal:  Cell Mol Neurobiol       Date:  2016-03-18       Impact factor: 5.046

10.  Genetic Analysis of the ZNF512B, SLC41A1, and ALDH2 Polymorphisms in Parkinson's Disease in the Iranian Population.

Authors:  Faranak Madadi; Mahmoud Shekari Khaniani; Ehsan Esmaili Shandiz; Hormoz Ayromlou; Safa Najmi; Babak Emamalizadeh; Shaghayegh Taghavi; Javad Jamshidi; Abbas Tafakhori; Gholam-Ali Shahidi; Hossein Darvish
Journal:  Genet Test Mol Biomarkers       Date:  2016-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.